US Stock MarketDetailed Quotes

HALO Halozyme Therapeutics

Watchlist
  • 46.960
  • -0.360-0.76%
Close Dec 20 16:00 ET
  • 46.960
  • 0.0000.00%
Post 20:01 ET
5.97BMarket Cap15.55P/E (TTM)

Halozyme Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
34.28%290.08M
4.67%231.35M
20.81%195.88M
25.62%829.25M
26.75%230.04M
3.38%216.03M
45.07%221.04M
38.25%162.14M
48.91%660.12M
77.93%181.5M
Operating revenue
34.28%290.08M
4.67%231.35M
20.81%195.88M
25.62%829.25M
26.75%230.04M
3.38%216.03M
45.07%221.04M
38.25%162.14M
48.91%660.12M
77.93%181.5M
Cost of revenue
-9.84%49.43M
-20.90%39.61M
-19.45%28.33M
38.09%192.36M
24.16%52.3M
15.86%54.82M
47.51%50.07M
120.89%35.17M
71.11%139.3M
95.12%42.12M
Gross profit
49.28%240.66M
12.15%191.75M
31.96%167.55M
22.29%636.89M
27.53%177.74M
-0.28%161.21M
44.37%170.97M
25.27%126.97M
43.91%520.81M
73.32%139.38M
Operating expense
6.21%77.46M
-2.61%74.51M
-1.59%72.01M
18.18%299.32M
18.25%76.71M
-6.93%72.93M
-9.31%76.51M
184.86%73.17M
194.53%253.28M
171.61%64.87M
Selling and administrative expenses
16.93%41.24M
-8.31%35.71M
-5.95%35.13M
3.94%149.18M
-0.37%37.61M
2.33%35.27M
-32.24%38.95M
170.04%37.36M
185.21%143.53M
174.06%37.75M
Research and development costs
6.56%18.46M
6.65%21.04M
6.30%19.11M
14.65%76.36M
-5.45%21.34M
3.69%17.32M
27.41%19.73M
51.68%17.98M
86.72%66.61M
123.25%22.57M
Depreciation amortization depletion
-12.68%17.76M
-0.41%17.76M
-0.40%17.76M
70.98%73.77M
290.20%17.76M
-25.20%20.34M
56.41%17.84M
--17.84M
--43.15M
--4.55M
-Depreciation and amortization
-12.68%17.76M
-0.41%17.76M
-0.40%17.76M
70.98%73.77M
290.20%17.76M
-25.20%20.34M
56.41%17.84M
--17.84M
--43.15M
--4.55M
Operating profit
84.87%163.2M
24.11%117.24M
77.58%95.54M
26.18%337.57M
35.60%101.04M
5.99%88.28M
177.33%94.46M
-28.90%53.8M
-3.03%267.53M
31.80%74.51M
Net non-operating interest income expense
-0.42%-4.52M
-0.67%-4.52M
0.79%-4.51M
-10.71%-18.76M
-14.22%-5.22M
40.05%-4.51M
-44.78%-4.49M
-158.27%-4.54M
-125.18%-16.95M
-122.38%-4.57M
Non-operating interest expense
0.42%4.52M
0.67%4.52M
-0.79%4.51M
10.71%18.76M
14.22%5.22M
-40.05%4.51M
44.78%4.49M
158.27%4.54M
125.18%16.95M
122.38%4.57M
Other net income (expense)
-64.01%6.47M
57.64%5.03M
67.61%4.99M
1,871.73%29.52M
529.11%5.36M
968.47%17.99M
437.78%3.19M
498.19%2.98M
91.61%-1.67M
157.40%852K
Gain on sale of security
35.27%6.47M
57.64%5.03M
67.61%4.99M
1,459.94%16.32M
529.11%5.36M
646.65%4.79M
437.78%3.19M
498.19%2.98M
-5.08%1.05M
157.40%852K
Special income (charges)
--0
----
----
586.73%13.2M
--0
586.73%13.2M
----
----
87.06%-2.71M
--0
-Less：Restructuring and merger&acquisition
--0
----
----
---13.2M
--0
---13.2M
----
----
--0
--0
-Less:Other special charges
----
----
----
----
----
----
----
----
-87.06%2.71M
--0
Income before tax
62.29%165.15M
26.39%117.74M
83.83%96.03M
39.94%348.33M
42.92%101.18M
38.06%101.76M
210.41%93.16M
-29.80%52.24M
0.16%248.92M
29.16%70.79M
Income tax
41.22%28.14M
33.13%24.5M
52.14%19.21M
42.63%66.74M
20.61%15.79M
65.02%19.92M
151.19%18.4M
-11.73%12.62M
130.34%46.79M
209.44%13.09M
Net income
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Net income continuous Operations
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Minority interest income
Net income attributable to the parent company
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
67.42%137.01M
24.74%93.25M
93.92%76.82M
39.31%281.59M
47.98%85.39M
32.78%81.84M
229.53%74.75M
-34.09%39.62M
-49.81%202.13M
-13.58%57.7M
Basic earnings per share
74.19%1.08
28.07%0.73
110.34%0.61
43.92%2.13
51.16%0.65
37.78%0.62
256.25%0.57
-34.09%0.29
-48.25%1.48
-10.42%0.43
Diluted earnings per share
72.13%1.05
28.57%0.72
106.90%0.6
45.83%2.1
54.76%0.65
38.64%0.61
250.00%0.56
-32.56%0.29
-47.45%1.44
-8.70%0.42
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024 (Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022
Total revenue 34.28%290.08M 4.67%231.35M 20.81%195.88M 25.62%829.25M 26.75%230.04M 3.38%216.03M 45.07%221.04M 38.25%162.14M 48.91%660.12M 77.93%181.5M
Operating revenue 34.28%290.08M 4.67%231.35M 20.81%195.88M 25.62%829.25M 26.75%230.04M 3.38%216.03M 45.07%221.04M 38.25%162.14M 48.91%660.12M 77.93%181.5M
Cost of revenue -9.84%49.43M -20.90%39.61M -19.45%28.33M 38.09%192.36M 24.16%52.3M 15.86%54.82M 47.51%50.07M 120.89%35.17M 71.11%139.3M 95.12%42.12M
Gross profit 49.28%240.66M 12.15%191.75M 31.96%167.55M 22.29%636.89M 27.53%177.74M -0.28%161.21M 44.37%170.97M 25.27%126.97M 43.91%520.81M 73.32%139.38M
Operating expense 6.21%77.46M -2.61%74.51M -1.59%72.01M 18.18%299.32M 18.25%76.71M -6.93%72.93M -9.31%76.51M 184.86%73.17M 194.53%253.28M 171.61%64.87M
Selling and administrative expenses 16.93%41.24M -8.31%35.71M -5.95%35.13M 3.94%149.18M -0.37%37.61M 2.33%35.27M -32.24%38.95M 170.04%37.36M 185.21%143.53M 174.06%37.75M
Research and development costs 6.56%18.46M 6.65%21.04M 6.30%19.11M 14.65%76.36M -5.45%21.34M 3.69%17.32M 27.41%19.73M 51.68%17.98M 86.72%66.61M 123.25%22.57M
Depreciation amortization depletion -12.68%17.76M -0.41%17.76M -0.40%17.76M 70.98%73.77M 290.20%17.76M -25.20%20.34M 56.41%17.84M --17.84M --43.15M --4.55M
-Depreciation and amortization -12.68%17.76M -0.41%17.76M -0.40%17.76M 70.98%73.77M 290.20%17.76M -25.20%20.34M 56.41%17.84M --17.84M --43.15M --4.55M
Operating profit 84.87%163.2M 24.11%117.24M 77.58%95.54M 26.18%337.57M 35.60%101.04M 5.99%88.28M 177.33%94.46M -28.90%53.8M -3.03%267.53M 31.80%74.51M
Net non-operating interest income expense -0.42%-4.52M -0.67%-4.52M 0.79%-4.51M -10.71%-18.76M -14.22%-5.22M 40.05%-4.51M -44.78%-4.49M -158.27%-4.54M -125.18%-16.95M -122.38%-4.57M
Non-operating interest expense 0.42%4.52M 0.67%4.52M -0.79%4.51M 10.71%18.76M 14.22%5.22M -40.05%4.51M 44.78%4.49M 158.27%4.54M 125.18%16.95M 122.38%4.57M
Other net income (expense) -64.01%6.47M 57.64%5.03M 67.61%4.99M 1,871.73%29.52M 529.11%5.36M 968.47%17.99M 437.78%3.19M 498.19%2.98M 91.61%-1.67M 157.40%852K
Gain on sale of security 35.27%6.47M 57.64%5.03M 67.61%4.99M 1,459.94%16.32M 529.11%5.36M 646.65%4.79M 437.78%3.19M 498.19%2.98M -5.08%1.05M 157.40%852K
Special income (charges) --0 ---- ---- 586.73%13.2M --0 586.73%13.2M ---- ---- 87.06%-2.71M --0
-Less：Restructuring and merger&acquisition --0 ---- ---- ---13.2M --0 ---13.2M ---- ---- --0 --0
-Less:Other special charges ---- ---- ---- ---- ---- ---- ---- ---- -87.06%2.71M --0
Income before tax 62.29%165.15M 26.39%117.74M 83.83%96.03M 39.94%348.33M 42.92%101.18M 38.06%101.76M 210.41%93.16M -29.80%52.24M 0.16%248.92M 29.16%70.79M
Income tax 41.22%28.14M 33.13%24.5M 52.14%19.21M 42.63%66.74M 20.61%15.79M 65.02%19.92M 151.19%18.4M -11.73%12.62M 130.34%46.79M 209.44%13.09M
Net income 67.42%137.01M 24.74%93.25M 93.92%76.82M 39.31%281.59M 47.98%85.39M 32.78%81.84M 229.53%74.75M -34.09%39.62M -49.81%202.13M -13.58%57.7M
Net income continuous Operations 67.42%137.01M 24.74%93.25M 93.92%76.82M 39.31%281.59M 47.98%85.39M 32.78%81.84M 229.53%74.75M -34.09%39.62M -49.81%202.13M -13.58%57.7M
Minority interest income
Net income attributable to the parent company 67.42%137.01M 24.74%93.25M 93.92%76.82M 39.31%281.59M 47.98%85.39M 32.78%81.84M 229.53%74.75M -34.09%39.62M -49.81%202.13M -13.58%57.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 67.42%137.01M 24.74%93.25M 93.92%76.82M 39.31%281.59M 47.98%85.39M 32.78%81.84M 229.53%74.75M -34.09%39.62M -49.81%202.13M -13.58%57.7M
Basic earnings per share 74.19%1.08 28.07%0.73 110.34%0.61 43.92%2.13 51.16%0.65 37.78%0.62 256.25%0.57 -34.09%0.29 -48.25%1.48 -10.42%0.43
Diluted earnings per share 72.13%1.05 28.57%0.72 106.90%0.6 45.83%2.1 54.76%0.65 38.64%0.61 250.00%0.56 -32.56%0.29 -47.45%1.44 -8.70%0.42
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List